These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6102627)

  • 1. Clavulanic acid and amoxycillin: a clinical, bacteriological, and pharmacological study.
    Ball AP; Geddes AM; Davey PG; Farrell ID; Brookes GR
    Lancet; 1980 Mar; 1(8169):620-3. PubMed ID: 6102627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerability of an amoxycillin/clavulanic acid combination in the treatment of common bacterial infections. A general practitioner trial.
    Levenstein JH
    S Afr Med J; 1982 Jul; 62(5 Spec No):16A-20A. PubMed ID: 7046104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amoxycillin/clavulanic acid: a review of its antibacterial activity, pharmacokinetics and therapeutic use.
    Brogden RN; Carmine A; Heel RC; Morley PA; Speight TM; Avery GS
    Drugs; 1981 Nov; 22(5):337-62. PubMed ID: 7037354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmentin (amoxycillin and clavulanic acid) therapy in complicated infections due to beta-lactamase producing bacteria.
    Leigh DA; Bradnock K; Marriner JM
    J Antimicrob Chemother; 1981 Mar; 7(3):229-36. PubMed ID: 6974165
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of chancroid by clavulanic acid with amoxycillin in patients with beta-lactamase-positive Haemophilus ducreyi infection.
    Fast MV; Nsanze H; D'Costa LJ; Plummer FA; Karasira P; Maclean IW; Ronald AR
    Lancet; 1982 Sep; 2(8297):509-11. PubMed ID: 6125676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Augmentin (amoxycillin and clavulanic acid) in the treatment of urinary tract infections.
    Leigh A
    Scott Med J; 1982; 27 Spec No.():S28-34. PubMed ID: 6984778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment with amoxicillin and clavulanic acid of urinary tract infections in patients with spinal injuries].
    Du Plessis DJ; Celliers D; Van Rensburg AJ; Lindeque KP
    S Afr Med J; 1982 Jul; 62(5 Spec No):8A-11A. PubMed ID: 6979806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of clinical isolates to expanded-spectrum beta-lactams alone and in the presence of beta-lactamase inhibitors.
    Qadri SM; Ueno Y; Cunha BA
    Chemotherapy; 1996; 42(5):334-42. PubMed ID: 8874972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The in vitro activity of amoxycillin with clavulanic acid against clinically significant bacteria. A multicentre study.
    Van den Ende J; Gricius ME; De Klerk HC; Neiteler BF; Forder AA; Venter L; Hallett AF; Koornhof HJ; Robinson R; Van Rensburg AJ; Lindeque KP
    S Afr Med J; 1982 Jul; 62(5 Spec No):5A-8A. PubMed ID: 6979805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A combination of amoxycillin with clavulanic acid (Augmentin) in various types of urinary tract infections caused by microbes producing beta-lactamase].
    Prát V; Horcicková M; Hatala M; Liska M; Matousovic K
    Cas Lek Cesk; 1985 Jun; 124(23):711-4. PubMed ID: 3874692
    [No Abstract]   [Full Text] [Related]  

  • 11. The history and background of Augmentin.
    Rolinson GN
    S Afr Med J; 1982 Jul; 62(5 Spec No):3A-4A. PubMed ID: 6979804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The protective effect of clavulanic acid in a combined formulation on the concentration of amoxycillin in the urine of patients with urinary tract infections.
    Lindeque KP
    S Afr Med J; 1982 Jul; 62(5 Spec No):12A-13A. PubMed ID: 7046103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergy of amoxycillin combined with clavulanate and YTR 830 in experimental infections in mice.
    Aronoff SC; Jacobs MR; Labrozzi PH; Yamabe S
    J Antimicrob Chemother; 1986 Aug; 18(2):271-6. PubMed ID: 3019987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A controlled trial of amoxycillin with clavulanic acid (BRL 25000) against doxycycline in chronic bronchitis.
    Ulmer WT; Zimmermann I
    J Int Med Res; 1981; 9(5):372-7. PubMed ID: 7028534
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro susceptibility of Staphylococcus aureus towards amoxycillin-clavulanic acid, penicillin-clavulanic acid, dicloxacillin and cefuroxime.
    Skov R; Frimodt-Møller N; Espersen F
    APMIS; 2002 Aug; 110(7-8):559-64. PubMed ID: 12390414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of beta-lactam beta-lactamase inhibitor combinations against extended spectrum Beta-lactamase producing Enterobacteriaceae in urinary isolates.
    Afridi FI; Farooqi BJ
    J Coll Physicians Surg Pak; 2012 Jun; 22(6):358-62. PubMed ID: 22630093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amoxicillin-clavulanic acid in treatment of urinary tract infection due to gram-negative bacteria resistant to penicillin.
    Martinelli R; Lopes AA; de Oliveira MM; Rocha H
    Antimicrob Agents Chemother; 1981 Dec; 20(6):800-2. PubMed ID: 7034642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of amoxycillin/clavulanic acid in experimental Staphylococcus aureus endocarditis in the rat.
    Catherall EJ; Irwin R; Mizen LW
    J Antimicrob Chemother; 1991 Jan; 27(1):117-26. PubMed ID: 2050588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Timentin and beta-lactamases.
    Labia R; Morand A; Péduzzi J
    J Antimicrob Chemother; 1986 May; 17 Suppl C():17-26. PubMed ID: 3487538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amoxycillin-clavulanic acid combination in bronchopulmonary infection due to beta-lactamase-producing Branhamella catarrhalis. Preliminary report.
    Thornley PE; Aitken JM; Nichol GM; Slevin NJ
    Drugs; 1986; 31 Suppl 3():113-4. PubMed ID: 3525087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.